What is the Projected CAGR value of the Tourette Syndrome Market ?
Tourette Syndrome Market is expected to grow at a CAGR of 10.5% during the forecast period 2024-2031.
Who are the key players in Tourette Syndrome Market ?
Major players are H. Lundbeck A/S, Emalex Biosciences, Inc., Teva Pharmaceutical Industries Ltd., Therapix Biosciences Ltd., Neurocrine Bioscience Inc., Eli Lilly and Company, Reviva Pharmaceuticals Inc., Bausch Health Companies Inc., Janssen Pharmaceuticals, and Mylan N.V.